Clinical Trials Browser

Lymphoma, B-Cell × palbociclib × 30 days × Clear all

NCT03478514 2026-04-09

Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma

Phase 2 Active not recruiting

Lymphoma, B-Cell, Lymphoma, Mantle-Cell